Current Status of the Cost Burden of First-Line Systemic Treatment for Patients with Advanced Hepatocellular Carcinoma in Japan, 2021-22
JAPANESE JOURNAL OF CLINICAL ONCOLOGY(2024)
Key words
hepatocellular carcinoma,treatment cost,immune checkpoint inhibitor,tyrosine kinase inhibitor,cost burden
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined